ABSTRACT A mixture of the 5.6S hydrophobic dimer and the asymmetric, tail-containing (17 + 13)S forms of acetylcholinesterase (acetylcholine acetylhydrolase, EC 3.1.1.7) from Torpedo californica was used to immunize mice, and spleen cells from these mice were used to produce nine hybridoma lines secreting antibodies against acetylcholinesterase. Antibodies from one of the lines showed a 100-fold greater affinity for the 5.6S species when compared with the catalytic subunits of the (17 + 13)S species. This difference in specificity was retained after denaturation of the two acetylcholinesterase species. Another line produced antibody directed only to structural subunits of the (17 + 13)S species, whereas the remaining seven antibodies exhibited nearly equivalent crossreactivity for all of the forms of acetylcholinesterase. Tryptic peptides were generated from the catalytic subunits of the 5.6S and tail-containing acetylcholinesterase species, and high-pressure liquid chromatographic profiles show at least two distinct peptides in the catalytic subunits for each enzyme species. Some of these peptides exhibit retention times different from those of the identified glycopeptides. Thus, it is likely that the catalytic subunits of two molecular forms of acetylcholinesterase differ in primary structure and sites of antigenicity.
Acetylcholinesterase (acetylcholine acetylhydrolase, EC 3.1.1.7) from the Torpedo electric organ exists as two distinct structural forms: a hydrophobic dimer of catalytic subunits with a sedimentation coefficient of 5.6 S and an elongated, dimensionally asymmetric form that sediments as discrete 17S and 13S entities (1) (2) (3) (4) (5) . The enlongated or tail-containing species contain between 8 and 12 catalytic subunits disulfide-linked to distinct collagenous and noncollagenous structural subunits (2) . The structural subunits of the 17S and 13S species can be removed by proteolysis, yielding an 11S species that retains full catalytic activity. The 11S form proves to be of value for comparing the structure of catalytic subunits of the elongated form with the hydrophobic form of acetylcholinesterase. The hydrophobic 5.6S acetylcholinesterase is devoid of structural subunits and appears to be a simple dimer of the catalytic subunits.
Based on a variety of studies of the structure and location of the acetylcholinesterase species and their reassociation with various membrane fractions, the elongated forms all appear to be exported to and deposited in the basal lamina of the synapse (6) (7) (8) , whereas the hydrophobic globular forms are associated with plasma membrane of the cell (3, 9) . The hydrophobic form associates with membranes and other hydrophobic proteins and even the purified protein in the absence of detergent exists as an aggregate. Both the elongated and globular hydrophobic species are found also in mammalian systems. The distribution of the various molecular forms appears under precise cellular regulation. Developmental factors, innervation, and muscle activity are known to influence the disposition of acetylcholinesterase species (cf. ref. 10) .
The asymmetric and globular forms in Torpedo exhibit indistinguishable catalytic behavior and susceptibilities to inhibitors (4, 5) . More recent characterization has revealed different electrophoretic behaviors of the catalytic subunits of the two forms and possible differences in their compositions (3) .
A fundamental question that underlies the above considerations and future studies on the regulation of acetylcholinesterase is whether the multiple molecular forms of this enzyme simply arise from alternative processing and assembly steps for a common catalytic subunit or whether separate genes encode for each form of the enzyme. To approach this question we have used hybridoma techniques and peptide separations to examine structural differences in the catalytic subunits from the various molecular forms of acetylcholinesterase.
MATERIALS AND METHODS
Immunization, Fusion, Antibody Screening, and Cloning. The (17 + 13)S, 11S, and 5.6S forms of acetylcholinesterase have been isolated and purified by previously described affinity chromatographic techniques (1) (2) (3) . A 75%/25% mixture of purified (17 + 13)S and 5.6S forms of the enzyme was used as the immunogen. On day 1, BALB/CJ mice were injected subcutaneously with 100 ,g of purified acetylcholinesterase in Freund's complete adjuvant; on day 25, 100 ,g of enzyme in Freund's incomplete adjuvant was injected intraperitonealy; on day 28, 100 ,ug of enzyme was administered intravenously; and on day 31, the spleens were harvested for fusion.
Spleen cells were fused by using polyethylene glycol 1000 with either the P3x63Ag8.653 mouse myeloma line (antibodysecreting cell lines 2C8, 2E6, 4E7, 4F3, 4F11, and 4G1) or the SP2/0-Agl4 mouse myeloma line (antibody-secreting cell lines 2G4, 9D1, and 11D5). The fusion and cloning procedures are detailed elsewhere (11) . Antibody-secreting cell lines were identified by a solid-phase microtiter plate radioimmunoassay (12) utilizing 1.5 ,ug of purified acetylcholinesterase per well. The second antibody was trivalent rabbit anti-mouse antiserum (IgG, IgA, IgM), affinity purified by the method of Ternznck and Avrameas (13) and labeled with M2I (14) .
Determination of the isotype of each monoclonal antibody was made by using tissue culture supernatants at concentrations that bound '50% of maximum counts in a radioimmunoassay. Details of the competition assay have been described (11) .
Characterization of Anti-Acetylcholinesterase Antibodies. Culture supernatants from the cell lines were precipitated with Abbreviation: ELISA, enzyme-linked immunoadsorbent assay.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Purification of the Monoclonal Antibodies. Rabbit anti-mouse immunoglobulins G. M, and A (Cappel Laboratories, Cochranville, PA; 100 mg) were coupled with 56 ml of CNBr-activated Sepharose 4B; =50 ml of culture supernatant from the cell lines was mixed with a 10-ml slurry of the immunoglobulincoupled Sepharose 4B. After incubation overnight at 40C with gentle agitation, the slurry was poured into a column and rinsed with 10 (Fig. 2) . Because collagenase treatment at 250C does not cleave the 100-kilodalton noncollagenous peptide or effect its removal from the catalytic subunits (2), it is likely that the immunogenic region is located on the collagenous tail units. Moreover, denaturation of the enzyme by guanidine'HCl in the presence of dithiothreitol also resulted in a loss of immunoreactivity. Thus, 4F3 is likely to be directed to the native tail unit. The distal portion of the tail unit is believed to have a triple helical structure similar to collagenous sequences in basement membranes (15) .
A second selective antibody was 4E7, which in the ELISA showed nearly a 100-fold preference for the 5.6S species over the 11S species (Fig. 3) (Fig. 4) . Lastly, the formation of a complex with the 5.6S enzyme could be demonstrated directly by sedimentation analysis after incubation of antigen and antibody. With the higher stoichiometric ratios of 4E7 antibody to acetylcholinesterase, formation of broadened peaks of higher sedimentation coefficients was observed (Fig.  5) . These likely represent formation of multivalent complexes, as both the antibody and acetylcholinesterase would be expected to be bivalent. Larger Fig. 1 , and the loss of reactivity probably reflects the inability of the low molecular weight peptides to adhere to the solid phase. o, Native acetylcholinesterase; *, treatment with collagenase (1 pg/ml for 1 hr) at 37TC; m, treatment with collagenase (1 ,ug/ml for 1 hr) at 250C; A, treatment with trypsin (5 jig/ml for 1 hr) at 25TC. 16.5 ,ug per assay; total acetylcholinesterase, 37 ng). Precipitation was achieved with protein A and values are compared with the total amount of radioactivity precipitated with trichloroacetic acid. the electrophoretic behavior of the reduced and dissociated catalytic subunits of the enzyme in NaDodSO4 (2) .
From the amino acid compositions, we would expect to obtain around 60 tryptic peptides from the catalytic subunits of acetylcholinesterase; in the gradient elution, approximately 55 peptides could be identified (Fig. 6) Although the profiles of the two enzymes showed a general similarity, we identified at least four peptides that differ in the two profiles. Peptides 10 and 42 were absent in 5.6S acetylcholinesterase, whereas peptides 45 and 47 appeared to be absent in 11S acetylcholinesterase. In addition, qualitative differences appeared in peaks 6, 14, 17, 27, and 48, but further characterization would be necessary to establish these as different peptides. The glycopeptides were provisionally located by comparing paired HPLC profiles run prior to and after chromatography over separate columns of wheat germ agglutinin and ricin linked to Sepharose-4B. By the criterion of lectin adsorption, the majority of peaks that differed between the two enzymes did not contain oligosaccharide residues. Thus, the differences in tryptic peptides between the 5.6S and 11S enzymes cannot solely be attributed to post-translational alterations in the oligosaccharide residues. Hence, we would expect the catalytic subunits of the two forms of acetylcholinesterase to have different amino acid sequences.
DISCUSSION
The two general classes of acetylcholinesterase found in Torpedo and mammalian muscle can be categorized as asymmetric and globular. The asymmetric species contain a variable number of catalytic subunits linked to a collagenase-sensitive tail unit. They are localized primarily in synaptic regions (16) and generally increase in content upon synaptogenesis (10) . After damage to the nerve and muscle membranes, plasma membranes are degraded, yet the basal lamina is retained along with its associated acetylcholinesterase (8) . Based on studies in electric organ of Torpedo and Electrophorus, it would appear that the tail unit is actually a component of the basal lamina (6) (7) (8) 15) . Torpedo acetylcholinesterase forms differ from those in Electrophorus in that a substantial percentage of a hydrophobic, globular species can be identified in Torpedo (3) (4) (5) .
The globular forms found in mammalian muscle appear to be both soluble and membrane-associated and are found as monomers through tetramers (17) . The globular forms precede the formation of synapses in development and do not show a preferential localization to synaptic regions. After irreversible inactivation of acetylcholinesterase in myotubes, active globular forms precede the appearance of the asymmetric forms (18) . The small quantities of acetyicholinesterase in mammalian muscle complicate detailed structural studies. However, the abundance of acetylcholinesterase in the Torpedo electrocyte allows isolation from an alternative source. The globular forms also appear first during the development of the Torpedo electrocyte (19) .
Pertinent to the considerations of the biosynthesis and assembly of the complex species of acetylcholinesterase is whether a common catalytic subunit prevails in the diverse molecular forms. As suggested previously (20) , should there be a common catalytic subunit, regulation of the distribution of acetylcholinesterase species would occur entirely at a post-translational stage, presumably during assembly of the catalytic and structural subunits. Under these circumstances one would expect both structural and immunologic identity of the catalytic subunits. Fambrough et al. (21) have isolated seven hybridoma lines secreting antibodies to mammalian erythrocyte acetylcholinesterase that show similar antibody specificity to the globular and asymmetric enzymes from muscle.
From our hybridoma cell lines, we have been able to isolate an antibody that shows a 100-fold difference in crossreactivity of the catalytic subunits from the hydrophobic dimer (a globular form) and the asymmetric form. These data, when coupled with an analysis of the tryptic peptides, suggest that the catalytic subunits differ both antigenically and in primary structure. Because most of the different peptides appear as nonglycopeptides, it is likely that either separate genes encode for acetylcholinesterase or alternative RNA processing (22) 
